🚚 Free shipping on all orders above $299 · 30 days money back guarantee · Helpline +1 251-332-4105

Celkeran 2 mg (Chlorambucil)

$84.00$2.80 per tablet · 30 tablets

Clokeran 2 mg Tablet is used for blood cancer & Hodgkin’s disease. Buy now at a cheap price in the US, UK & Australia with quick delivery!

Choose pack sizePrice per tablet shown

Want to order in bulk / B2B price?

Tracked, discreet delivery

Ships in discreet packaging with a tracking number. Free shipping on orders above $299.

30 days money back guarantee

Damaged, missing or only part of your order arrived? Choose a new package or a full refund.

Questions before you order?

Call +1 251-332-4105 or email order@pharmeasybank.com.

SECURE CHECKOUT
DISCOVER
MasterCard
VISA

Share

What Is Celkeran 2 mg?

Celkeran 2 mg (Chlorambucil) is an oral anticancer medicine belonging to the alkylating agent class of chemotherapy drugs.

Chlorambucil is a nitrogen mustard derivative that interferes with the genetic material of susceptible cells.

It has established historical applications in selected blood and lymphatic cancers, including chronic lymphocytic leukemia and certain lymphomas.

The medicine works by forming chemical bonds with cellular DNA.

These bonds can produce DNA cross-links, which interfere with DNA replication and normal cell division.

Cancer cells that cannot adequately repair this damage may stop dividing or undergo cell death.

However, chlorambucil can also damage healthy cells, particularly rapidly dividing cells in the bone marrow.

This can reduce the production of white blood cells, red blood cells and platelets.

Consequently, treatment may cause serious infections, anemia and bleeding complications.

The 2 mg tablet strength can be used by an oncology specialist to construct an individualized treatment regimen.

However, 2 mg is the amount of medicine in one tablet, not necessarily the prescribed daily dose.

Chlorambucil is an older chemotherapy medicine. Modern targeted treatments, immunotherapies and other chemotherapy regimens may be preferred for many patients depending on the cancer type and individual clinical circumstances.

Important: Celkeran 2 mg is not a general-purpose anticancer supplement or preventive medicine. It is a prescription cytotoxic drug requiring careful patient selection and ongoing monitoring.

How Does Celkeran 2 mg Work?

1. Belongs to the Alkylating Agent Class

Chlorambucil is a nitrogen mustard-derived alkylating chemotherapy agent.

2. Reaches Susceptible Cells

After oral administration and absorption, chlorambucil enters systemic circulation and reaches susceptible tissues.

3. Interacts With Cellular DNA

Chlorambucil forms covalent chemical bonds with components of DNA.

These interactions can produce DNA cross-links that interfere with normal DNA structure and function.

5. Disrupts DNA Replication

DNA damage prevents affected cells from accurately copying their genetic material.

6. Interferes With Cell Division

Cells with extensive DNA damage may be unable to complete normal division.

7. Promotes Cancer Cell Death

Unrepaired DNA damage may activate cellular pathways that lead to cell death.

8. Affects Normal Dividing Cells

Chlorambucil can also damage healthy cells, particularly blood-forming cells in the bone marrow.

Important: Chlorambucil is not selective for malignant cells alone. Its effects on normal tissues are responsible for significant treatment-related toxicity.

Uses of Celkeran 2 mg

1. Chronic Lymphocytic Leukemia (CLL)

Chlorambucil has been used to treat chronic lymphocytic leukemia, a cancer involving abnormal accumulation of certain lymphocytes.

It may help control disease activity in selected patients.

However, newer targeted therapies are preferred in many contemporary treatment settings.

2. Hodgkin Lymphoma

Chlorambucil has historical use in certain treatment regimens for Hodgkin lymphoma.

Current standard treatments generally involve other chemotherapy combinations and selected newer therapies.

3. Non-Hodgkin Lymphoma

Chlorambucil has been used in selected non-Hodgkin lymphoma subtypes.

Treatment depends on the exact lymphoma classification and current clinical recommendations.

4. Follicular Lymphoma

Chlorambucil has historical applications in certain indolent follicular lymphoma treatment regimens.

Modern options may include immunotherapy, targeted medicines and other systemic treatments.

5. Waldenström Macroglobulinemia

Chlorambucil has historically been used in selected patients with Waldenström macroglobulinemia.

Its role depends on disease characteristics and the availability of more suitable treatments.

6. Selected Indolent Lymphoid Malignancies

Chlorambucil may be considered for certain slowly progressing lymphoid cancers when an oncology specialist determines that it is appropriate.

7. Individualized Treatment in Selected Patients

Treatment decisions may consider age, frailty, other medical conditions, prior therapies and tolerance of available alternatives.

8. Specialist-Directed Oncology Treatment

Chlorambucil may be included in selected oncology protocols when the expected clinical benefit outweighs its risks.

Important: These indications are not interchangeable. Some applications are historical or jurisdiction-specific, and chlorambucil is not appropriate for every leukemia or lymphoma.

How to Take Celkeran 2 mg

Celkeran 2 mg must be taken exactly according to the oncology specialist’s instructions.

General Administration Instructions

  1. Confirm the prescribed treatment protocol.
  2. Verify the 2 mg tablet strength.
  3. Take only the number of tablets prescribed.
  4. Follow the oncology team’s instructions regarding food.
  5. Swallow tablets whole unless the manufacturer specifically instructs otherwise.
  6. Do not crush, split or chew cytotoxic tablets without specialist authorization.
  7. Do not independently increase or reduce the dose.
  8. Attend scheduled blood tests.
  9. Report fever, unusual bleeding or severe weakness immediately.
  10. Follow safe handling and storage precautions.

Dosage Information

Dosage DetailGeneral Guidance
Tablet Strength2 mg
RouteOral
Adult DosageIndividualized According to Cancer Type and Oncology Protocol
Pediatric DosageSpecialist-Directed
Administration FrequencyDepends on the Prescribed Regimen
Treatment DurationDetermined by Clinical Response and Tolerability
Dose AdjustmentBased on Blood Counts, Toxicity and Other Clinical Factors
Missed DoseContact the Oncology Team
MonitoringRegular Complete Blood Counts and Additional Tests as Indicated
Medical SupervisionMandatory

Is Celkeran 2 mg Taken Daily?

Some chlorambucil treatment regimens involve daily administration, while others use intermittent or cyclic schedules.

The correct frequency must be determined by the treating oncology specialist.

Is 2 mg a Low Dose of Chlorambucil?

The 2 mg strength refers to the amount of chlorambucil in one tablet.

It does not establish whether the patient’s prescribed regimen is low-dose or high-dose treatment.

Total dose and cumulative exposure determine much of the treatment-related risk.

Should Celkeran Be Taken With Food?

Some chlorambucil tablet formulations are recommended to be taken on an empty stomach.

Follow the exact manufacturer’s instructions and oncology prescription.

Can Celkeran Tablets Be Crushed?

Chlorambucil is a cytotoxic medicine.

Tablets should generally be swallowed whole and should not be crushed, broken or chewed.

What If a Dose Is Missed?

Contact the oncology team for instructions.

Do not take a double dose to compensate for a missed tablet.

What If an Extra Dose Is Taken?

An overdose may cause serious bone marrow suppression and neurological complications.

Seek emergency medical attention immediately.

How Long Does Celkeran 2 mg Take to Work?

The clinical response depends on the cancer type, disease burden, treatment regimen and individual patient characteristics.

After Administration

Chlorambucil is absorbed and begins exerting its cytotoxic effects.

During the Initial Treatment Period

The medicine may begin interfering with the survival and division of susceptible malignant cells.

Over Several Weeks

Changes in blood counts, lymph node size or other disease markers may become measurable.

During Subsequent Treatment Cycles

The oncology team evaluates treatment response, toxicity and whether therapy should continue.

Important: Bone marrow suppression can be delayed and may continue after treatment interruption or completion. Follow-up blood tests are essential.

Common Side Effects

Possible side effects include:

  • Nausea
  • Vomiting
  • Reduced appetite
  • Diarrhea
  • Fatigue
  • Weakness
  • Mouth irritation
  • Low white blood cell counts
  • Low platelet counts
  • Anemia
  • Increased infection risk
  • Skin rash
  • Menstrual changes
  • Reduced fertility

The severity of adverse effects depends on the treatment regimen, cumulative exposure and individual health factors.

Serious Side Effects

Seek urgent medical attention if any of the following occur:

  • Fever or chills
  • Severe or persistent infections
  • Unusual bruising
  • Uncontrolled bleeding
  • Severe weakness
  • Shortness of breath
  • Seizures
  • Severe confusion
  • Blistering or peeling skin
  • Severe allergic reactions
  • Persistent cough
  • New breathing difficulties
  • Symptoms of significant anemia

Important Serious Risks

Severe Bone Marrow Suppression: Chlorambucil can significantly reduce the production of white blood cells, red blood cells and platelets.

Serious Infections: Neutropenia and other immune effects may increase the risk of life-threatening infections.

Bleeding Complications: Thrombocytopenia may cause bruising, bleeding and other complications.

Secondary Malignancies: Chlorambucil is associated with an increased risk of treatment-related cancers, including leukemia.

Infertility: Chlorambucil may impair fertility in males and females, potentially permanently.

Fetal Harm: Chlorambucil can harm a developing fetus.

Seizures: Neurological toxicity, including seizures, has been reported.

Severe Skin Reactions: Rare serious skin reactions, including Stevens–Johnson syndrome and toxic epidermal necrolysis, have been reported.

Pulmonary Toxicity: Rare cases of serious lung complications, including pulmonary fibrosis, have been associated with chlorambucil.

Contraindications & Precautions

1. Allergy to Chlorambucil

Patients with known serious hypersensitivity to chlorambucil should not use the medicine.

2. Previous Chlorambucil Resistance

Treatment should be reassessed when the malignancy has demonstrated resistance to chlorambucil.

3. Bone Marrow Suppression

Patients with existing low blood cell counts require careful assessment.

4. Active Infections

Serious infections should be evaluated and managed during chemotherapy.

5. Pregnancy

Chlorambucil can cause fetal harm and requires strict pregnancy-related precautions.

6. Breastfeeding

Breastfeeding is not recommended during chlorambucil treatment.

7. Fertility

Chlorambucil may cause temporary or permanent infertility.

Fertility preservation should be discussed before treatment when appropriate.

8. Liver Disease

Patients with significant liver impairment may require dose modification and additional monitoring.

9. Kidney Disease

Renal function and overall clinical status should be considered when planning treatment.

10. Previous Chemotherapy

Previous cytotoxic treatment may increase the risk of cumulative bone marrow toxicity.

11. Previous Radiation Therapy

Prior radiation treatment may affect bone marrow reserve and treatment tolerance.

12. Seizure Disorders

Patients with a history of seizures require careful assessment because chlorambucil can cause neurological toxicity.

13. Live Vaccines

Live vaccines may be unsafe during chemotherapy-related immunosuppression.

14. Drug Interactions

The oncology team should review all medicines, particularly:

  • Other cytotoxic chemotherapy medicines
  • Immunosuppressive medicines
  • Medicines that suppress bone marrow function
  • Certain live vaccines
  • Treatments that increase infection or bleeding risk

15. Secondary Cancer Risk

Long-term or cumulative exposure to chlorambucil can increase the risk of secondary malignancies.

16. Cytotoxic Handling

Chlorambucil tablets require appropriate handling precautions.

Pregnant individuals should avoid handling damaged tablets or powder from broken tablets.

17. Treatment Monitoring

Regular blood counts and assessment of treatment response are essential.

18. Medical Monitoring

Healthcare professionals may assess:

  • Complete blood count
  • White blood cell count
  • Neutrophil count
  • Hemoglobin
  • Platelet count
  • Liver function
  • Kidney function
  • Infection symptoms
  • Bleeding symptoms
  • Neurological symptoms
  • Pulmonary symptoms
  • Treatment response
  • Cumulative drug exposure
  • Fertility considerations
  • Pregnancy status when applicable
  • Drug interactions
  • Need for dose interruption
  • Long-term complications

Potential Therapeutic Characteristics

  • Alkylating Antineoplastic Activity.
  • DNA Cross-Link Formation.
  • DNA Replication Inhibition.
  • Cytotoxic Activity Against Susceptible Lymphoid Cells.
  • Oral Chemotherapy Administration.
  • 2 mg Tablet Strength.
  • Historical Chronic Lymphocytic Leukemia Treatment.
  • Historical Lymphoma Treatment.
  • Specialist-Directed Oncology Regimens.
  • Individualized Treatment Planning.
  • Established Nitrogen Mustard Derivative.
  • Laboratory-Guided Treatment Monitoring.

Disadvantages / Limitations

  • Severe Bone Marrow Suppression Risk.
  • Increased Infection Risk.
  • Thrombocytopenia.
  • Anemia.
  • Bleeding Complications.
  • Nausea.
  • Vomiting.
  • Fatigue.
  • Reduced Appetite.
  • Potential Infertility.
  • Pregnancy-Related Harm.
  • Secondary Malignancy Risk.
  • Possible Seizures.
  • Rare Severe Skin Reactions.
  • Rare Pulmonary Toxicity.
  • Delayed Blood Count Suppression.
  • Requires Laboratory Monitoring.
  • Requires Oncology Supervision.
  • Not Suitable for Self-Medication.
  • Not Preferred for Every Leukemia or Lymphoma.
  • Cytotoxic Handling Precautions Required.

Important Notes

Brand Name: Celkeran.

Generic Name: Chlorambucil.

Strength: 2 mg.

Drug Class: Alkylating Antineoplastic Agent.

Therapeutic Category: Oncology / Anticancer Medicine.

Mechanism of Action: DNA Alkylation and Cross-Link Formation.

Route: Oral.

Primary Applications: Selected Leukemias and Lymphomas.

Dosage: Oncology Specialist-Directed.

Major Warning: Severe Bone Marrow Suppression.

Infection Risk: Increased.

Bleeding Risk: Increased.

Secondary Cancer Risk: Present.

Fertility Risk: Potentially Serious or Permanent.

Pregnancy: Can Cause Fetal Harm.

Breastfeeding: Not Recommended During Treatment.

Monitoring: Regular Complete Blood Counts.

Handling: Cytotoxic Medicine Precautions.

Storage: Follow Manufacturer-Specific Labeling.

Frequently Asked Questions

1. What is Celkeran 2 mg used for?

Celkeran 2 mg is described as containing chlorambucil, an alkylating chemotherapy medicine used for selected leukemias and lymphomas.

2. Is Celkeran 2 mg a chemotherapy medicine?

Yes. Chlorambucil is a cytotoxic anticancer medicine belonging to the alkylating agent class.

3. How does chlorambucil work?

Chlorambucil damages cellular DNA by forming chemical bonds and cross-links that interfere with DNA replication and cell division.

4. Can Celkeran 2 mg treat chronic lymphocytic leukemia?

Chlorambucil has established historical use in chronic lymphocytic leukemia, although newer targeted therapies are preferred for many patients.

5. Can Celkeran 2 mg treat lymphoma?

Chlorambucil has been used for selected lymphoma types. Treatment suitability depends on the specific diagnosis and current oncology guidelines.

6. Is Celkeran 2 mg taken daily?

Some regimens involve daily administration, while others use intermittent schedules. The oncology specialist determines the correct regimen.

7. Is Celkeran 2 mg a low-dose chemotherapy tablet?

The tablet contains 2 mg of chlorambucil, but treatment intensity depends on the total prescribed dose and schedule.

Product DetailsInformation
Product NameCelkeran 2 mg
Brand NameCelkeran
Generic NameChlorambucil
Active IngredientChlorambucil
Strength2 mg
Dosage FormOral Tablet – Verify Product Packaging
Drug ClassAlkylating Antineoplastic Agent
Therapeutic CategoryOncology / Anticancer Medicines
Primary UsesSelected Leukemias and Lymphomas
Mechanism of ActionDNA Alkylation and Cross-Link Formation
Route of AdministrationOral
Dosage FrequencyAccording to Oncology Prescription
Treatment DurationDepends on Cancer Type and Treatment Protocol
ManufacturerVerify Original Packaging
Pack SizeVerify Original Packaging
Prescription StatusPrescription-Only Cytotoxic Medicine
StorageFollow Manufacturer-Specific Labeling
Medical SupervisionRequired by an Oncology Specialist
Pack sizes30 tablets, 60 tablets, 90 tablets
Bulk / B2B price inquiry

Tell us what you need and we’ll reply by email.